CVS Health (CVS) Tops Q2 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
CVS Health (CVS) PT Raised to $90 at RBC Capital
August 9, 2018 8:21 AM EDTRBC Capital raised its price target on CVS Health (NYSE: CVS) to $90.00 (from $84.00) while maintaining an Outperform rating.
Analyst George Hill views the updates on the Aetna transaction, PBM rebate retention, and the potential impact of regulatory changes positively and largely in-line with our positive view.
... More